Nascent Biotech
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Nascent Biotech's balance sheet done over the years? Its assets were worth $552,120 last year, which is more than in the previous period. 146% of Nascent Biotech’s total assets is currently financed by debt. Its liabilities reached the amount of $808,794, which means an decrease by -48% compared compared to last year.
Debt to Assets
| 2015 | 937601 | 3.14M | 335.39% |
|---|---|---|---|
| 2016 | 1401310 | 2.97M | 211.95% |
| 2017 | 899760 | 165.99K | 18.45% |
| 2018 | 116994 | 203.37K | 173.83% |
| 2019 | 131472 | 613.63K | 466.74% |
| 2020 | 3218 | 2.87M | 89463.08% |
| 2021 | 751435 | 1.22M | 162.88% |
| 2022 | 105414 | 776.89K | 736.99% |
| 2023 | 255002 | 1.55M | 608.29% |
| 2024 | 552120 | 808.79K | 146.49% |
NBIO Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 372.12K | 172.18K | 94.41K | 1.43K | 3.21K | 131.47K | 116.99K | 129.80K | 573.35K | 107.57K |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 750K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 180K | 82.81K | 11K | 0 | 0 | 0 | 0 | 0 | 0 | 2.06K |
Total current assets | 552.12K | 255.00K | 105.41K | 751.43K | 3.21K | 131.47K | 116.99K | 129.80K | 573.35K | 109.63K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 769.95K | 827.96K | 827.96K |
Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 769.95K | 827.96K | 827.96K |
Total assets | 552.12K | 255.00K | 105.41K | 751.43K | 3.21K | 131.47K | 116.99K | 899.76K | 1.40M | 937.60K |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 123.21K | 1.28M | 0 | 0 | 0 | 600K | 0 |
Short term debt | 122.5K | 389.59K | 0 | 161.73K | 138.81K | 0 | 0 | 0 | -2.33M | 0 |
Total current liabilities | 808.79K | 1.55M | 776.89K | 1.22M | 2.87M | 613.63K | 203.37K | 165.99K | 2.97M | 3.08M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 776.89K | 0 | 0 | 525.63K | 203.37K | 0 | 600K | 0 |
Total non-current liabilities | 0 | 0 | 776.89K | 0 | 0 | 525.63K | 203.37K | 151.65K | 600K | 60K |
Total liabilities | 808.79K | 1.55M | 776.89K | 1.22M | 2.87M | 613.63K | 203.37K | 165.99K | 2.97M | 3.14M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |